Professor Timothy Tree
Professor of Immune Regulation and Immunotherapy
Research interests
- Immunology
Biography
Professor Timothy Tree is a specialist in human T cell immunology with particular expertise in analysing the function of regulatory T cells in human health and disease. He currently leads a team of researchers based at Guy’s Hospital including clinicians, post-doctoral research scientists and PhD students who focus on translational medicine projects trying to unravel the basic biology of autoimmune and inflammatory disorders, such as type 1 diabetes and motor neurone disease; and develop novel therapies to halt these devastating diseases.
His work is funded by a range of medical research charities, government councils and pharmaceutical companies and includes participation in large national and international clinical trials. In addition to research activities, Tim also enjoys teaching on a wide range of undergraduate, postgraduate and professional courses including biomedical sciences and medicine. Tim was educated at Imperial College where he first read Biochemistry and then completed a doctorate in Immunology.
Research
Tree Group
Translational medicine projects trying to unravel the basic biology of autoimmune and inflammatory disorders and develop novel therapies to halt these devastating diseases.
PISA: Prenatal drivers of infant ISlet Autoimmunity
As childhood onset of T1D becomes more prevalent, there is an increasing need to understand how early life exposures could influence the development of the child and predispose to the development of autoimmunity.
News
Treatment for Motor Neurone Disease shows promise
A trial investigating a new treatment for amyotrophic lateral sclerosis (ALS) has shared promising results.
100 years of insulin: How immunotherapy could be the future of diabetes treatment
This year is the 100th anniversary of the discovery of insulin.
Exposure to SARS-CoV-2 during pregnancy impacts the developing immune system of the fetus
New research from King’s suggests COVID-19 infection in the mother alters the immune system of the baby in utero.
Potential new treatment for ALS shows promise in clinical trial
Researchers have disclosed the results of a potential new treatment for amyotrophic lateral sclerosis (ALS).
Research
Tree Group
Translational medicine projects trying to unravel the basic biology of autoimmune and inflammatory disorders and develop novel therapies to halt these devastating diseases.
PISA: Prenatal drivers of infant ISlet Autoimmunity
As childhood onset of T1D becomes more prevalent, there is an increasing need to understand how early life exposures could influence the development of the child and predispose to the development of autoimmunity.
News
Treatment for Motor Neurone Disease shows promise
A trial investigating a new treatment for amyotrophic lateral sclerosis (ALS) has shared promising results.
100 years of insulin: How immunotherapy could be the future of diabetes treatment
This year is the 100th anniversary of the discovery of insulin.
Exposure to SARS-CoV-2 during pregnancy impacts the developing immune system of the fetus
New research from King’s suggests COVID-19 infection in the mother alters the immune system of the baby in utero.
Potential new treatment for ALS shows promise in clinical trial
Researchers have disclosed the results of a potential new treatment for amyotrophic lateral sclerosis (ALS).